Global Lyme Alliance Issues RFP for Innovative Research Projects

With some 329,000 new cases reported annually, Lyme disease is the fastest growing vector-borne disease in the U.S. Indeed, the number of Lyme cases has increased nearly twenty-five-fold since national reporting began in 1982, and yet there are no accurate diagnostic tests for the disease, no tests to prove that Lyme bacteria have been eradicated, and no tests to show that an individual has been cured.

To address this growing problem, the Global Lyme Alliance has issued a Request for Proposals aimed at advancing the identification, treatment, and cure of Lyme and tick-borne diseases.

Through the RFP, Grants of up to $175,000 will be awarded in support of innovative research efforts in areas that include but are not limited to anti-microbial development, personalized medicine, identification and continuing treatment of Lyme, new diagnostic technologies, and the ecology of emerging tick-borne diseases. Small-scale grants of up to $100,000 for proof-of-concept studies lasting up to six months can be requested.

See the GLA website for complete program guideline and application instructions.

VIEW ANOTHER RFP RELATED TO MEDICAL RESEARCH

Deadline: June 30, 2018